-
公开(公告)号：KR1020100110434A
公开(公告)日：2010-10-13
申请号：KR1020090028760
申请日：2009-04-03
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K39/112 , C12N5/07 , A61K39/10 , A61P37/00
CPC classification number: A61K39/0275 , A61K2039/522
Abstract: PURPOSE: A method for attenuating pathogen by co-culture of pathogen and neutrophil is provided to attenuate without high technology and safely apply to human body. CONSTITUTION: A pathogen is attenuated by co-culture of pathogen and neutrophils. The neutrophil is isolated from poultry, pig, lamb, horse, cat, dog or human. A method for co-culture of pathogen and neutrophil comprises: a step of co-culture of neutrophili and pathogen for 10 minutes to two hours; a step of killing pathogen; and a step of collecting and dissolving neutrophil. The attenuated pathogen is ST31-N5th-1(KACC 91447P) or ST31-N20th-B10th-12(KACC 91448P). A vaccine composition contains attenuated pathogenic mutant.
Abstract translation: 目的：通过病原体和嗜中性粒细胞的共培养来减轻病原体的方法，无需高技术的减毒，安全应用于人体。 构成：通过病原体和嗜中性粒细胞的共培养来减轻病原体。 嗜中性粒细胞与家禽，猪，羊，马，猫，狗或人类分离。 病原体和嗜中性粒细胞的共培养方法包括：将嗜中性粒细胞和病原体共培养10分钟至2小时的步骤; 杀死病原体的一个步骤; 和收集和溶解嗜中性粒细胞的步骤。 减毒病原体是ST31-N5th-1（KACC91447P）或ST31-N20th-B10th-12（KACC91448P）。 疫苗组合物含有减毒致病突变体。
-
62.发明公开동물의 면역능을 증강시키는 벌나무가지 추출물 및 이를함유하는 면역증강제 无效用于改善动物免疫的ACER TEGMENTOSUM MAXIM RAMULUS的提取物和用于改善含有其的免疫的试剂
公开(公告)号：KR1020090021610A
公开(公告)日：2009-03-04
申请号：KR1020070086250
申请日：2007-08-27
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: Provided is an immunity improver using acer tegmentosum maximowocz extract which improves a function of a nonspecific defense against pathogen and increases activity of animal immunocytes such as neutrophil and macrophages. An immunity improver using acer tegmentosum maximowocz extract comprises acer tegmentosum maximowocz extract as an active ingredient. A method for preparing the acer tegmentosum maximowocz extract includes a step of extracting the extract from the dried acer tegmentosum maximowocz at a temperature of 90~100°C by hot distilled-water.
Abstract translation: 本发明提供了一种免疫改良剂，其使用宏碁提取物，其改善对病原体的非特异性防御的功能，并增加动物免疫细胞如嗜中性粒细胞和巨噬细胞的活性。 使用槭树提取物的抗微生物改良剂作为活性成分。 本发明提供了一种用于制备尖角果胶提取物的方法，其特征在于，在90〜100℃的温度下，通过热蒸馏水从干燥的青蒿中提取提取物。
-
公开(公告)号：KR1020090013599A
公开(公告)日：2009-02-05
申请号：KR1020070077854
申请日：2007-08-02
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K39/02 , A61P37/02 , A61K39/085
CPC classification number: A61K39/05 , C12R1/47 , Y10S435/887 , Y10S514/885
Abstract: An immunostimulant containing the lystic extract of Streptomyces albus is provided to reinforce the functions of various immune cells having the major role in the disease defense, thereby increasing the specific and nonspecific resistance to the disease infection of animals. The immunostimulant contains the lystic extract of Streptomyces albus which is prepared by cultivating Streptomyces albus in yeast malt extract agar broth at 26 deg. C for 72 hours, centrifuging the cultured fluid at 3000Xg for 30 minutes and collecting it, rinsing the collected pellet with phosphate buffered saline(PBS) of pH 7.2 and suspending the rinsed pellet in PBS, adding 5% of TNT solution containing 50mM of Tris-HCl, 0.15M of NaCl and 4% Triton x-114 as solubilizing agent into the Streptomyces albus suspension, stirring the mixture at room temperature for 2-3 days to solubilize the Streptomyces albus, and regulating pH of the solution to 6.5-7.2, and drying the solution in the thermostatic chamber.
Abstract translation: 提供含有链霉菌（Streptomyces albus）的提取物的免疫刺激剂，以增强在疾病防御中具有主要作用的各种免疫细胞的功能，从而增加对动物疾病感染的特异性和非特异性抗性。 免疫刺激剂含有通过在26度的酵母麦芽提取物琼脂培养基中培养链霉菌（Streptomyces albus）而制备的链霉菌链霉菌的提取物。 培养72小时，将培养液以3000Xg离心30分钟并收集，用pH7.2的磷酸盐缓冲盐水（PBS）冲洗收集的沉淀物，并将漂洗的沉淀悬浮于PBS中，加入5％含有50mM Tris -HCl，0.15M NaCl和4％Triton x-114作为增溶剂加入到Streptomyces albus悬浮液中，在室温下搅拌混合物2-3天以溶解链霉菌，并将溶液的pH调节至6.5-7.2 ，并干燥恒温室中的溶液。
-
公开(公告)号：KR1020090004023A
公开(公告)日：2009-01-12
申请号：KR1020070067899
申请日：2007-07-06
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: G01N33/569 , G01N33/53
Abstract: A method for diagnosing the infection of vancomycin-resistant Enterococcus is provided to allow whether vancomycin-resistant Enterococcus is infected or not rapidly and effectively. A method for diagnosing the infection of vancomycin-resistant Enterococcus uses the antigen-antibody reaction with the specific antigen of vancomycin-resistant Enterococcus. Preferably the vancomycin-resistant Enterococcus is any one selected from Vancomycin-resistant Enterococcus phythium (VREFM), Vancomycin-resistant Enterococcus faecalis (VREFS), Vancomycin-resistant Enterococcus gallinarum (VREG), and Vancomycin-resistant Enterococcus casseliflavus.
Abstract translation: 提供了用于诊断耐万古霉素肠球菌感染的方法，以使万古霉素耐药肠球菌感染或不迅速有效地感染。 用于诊断耐万古霉素肠球菌的感染的方法使用与万古霉素耐药性肠球菌的特异性抗原的抗原 - 抗体反应。 优选地，万古霉素耐药性肠球菌是选自万古霉素耐药性肠球菌（VREFM），万古霉素耐药性粪肠球菌（VREFS），万古霉素耐药性肠球菌（VREG）和万古霉素耐药性肠球菌的任何一种。
-
公开(公告)号：KR1020080093488A
公开(公告)日：2008-10-22
申请号：KR1020070037227
申请日：2007-04-17
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K36/233 , A61P37/00
Abstract: An extract of Bupleuri Radix is provided to increase various activities of main immunocytes of an animal such as granulocyte and macrophage and induce strong defence capability on attach inoculation of pathogenic bacteria. A composition comprising the same extract is provided to be used as an animal medicine such as an animal immuno-enhancing agent and a vaccine adjuvant and a feed additive for treating and preventing animal diseases efficiently. A method for purifying an extract of Bupleuri Radix comprises the steps of: (a) heat-treating the Bupleuri Radix with hot water at a temperature of 80-120 deg.C for 2-3 hours to obtain a crude extract; (b) concentrating the crude extract; and (c) filtering the concentrate to obtain a polysaccharide fraction by filtering paper and microorganism filtering. An extract of Bupleuri Radix purified by the method is a Bupleuri Radix polysaccharide, of which sugar is a glycoprotein including a protein. A composition for increasing immunity comprises the extract of Bupleuri Radix as an active ingredient and a pharmaceutically acceptable carrier or an excipient. An animal immunity enhancing agent, a vaccine adjuvant, or a feed additive for an animal comprises the composition for increasing immunity as an active ingredient.
Abstract translation: 提供柴胡提取物，以增加动物如粒细胞和巨噬细胞的主要免疫细胞的各种活性，并在附着接种病原菌时诱导强大的防御能力。 提供包含相同提取物的组合物用作动物药物，例如动物免疫增强剂和疫苗佐剂和用于有效治疗和预防动物疾病的饲料添加剂。 纯化柴胡提取物的方法包括以下步骤：（a）在80-120℃的温度下用热水热处理柴胡，2-3小时，得到粗提物; （b）浓缩粗提物; 和（c）过滤浓缩物以通过滤纸和微生物过滤获得多糖级分。 通过该方法纯化的柴胡提取物是一种柴胡甘草多糖，其中糖是包含蛋白质的糖蛋白。 用于增加免疫力的组合物包含作为活性成分的柴胡提取物和药学上可接受的载体或赋形剂。 动物免疫增强剂，疫苗佐剂或用于动物的饲料添加剂包括用于增加免疫力作为活性成分的组合物。
-
Patent Agency Ranking
公开(公告)号：KR1020080092007A
公开(公告)日：2008-10-15
申请号：KR1020070035257
申请日：2007-04-10
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K36/804 , A61P17/00
CPC classification number: Y02A50/471
Abstract: An extract of Rehmannia glutinosa is provided to increase various activities of neutrophil or macrophages and induce strong protectivity on attack inoculation of pathogenic bacteria, thereby being used as an immune enhancing agent, a vaccine adjuvant, an adjuvant therapeutic agent and a feed additive for an animal. An extract of Rehmannia glutinosa enhances immunity of an animal by increasing the activity of immunocyte such as neutrophil or macrophages. A method for preparing the extract of Rehmannia glutinosa comprises the steps of: (a) boiling dried Rehmannia glutinosa with distilled water to obtain the extract of Rehmannia glutinosa; (b) filtering the extract; and (c) hydrolyzing a filtrate.
Abstract translation: 提供地黄提取物以增加嗜中性粒细胞或巨噬细胞的各种活性，并在致病细菌的侵袭接种中诱发强的保护作用，从而用作免疫增强剂，疫苗佐剂，佐剂治疗剂和用于动物的饲料添加剂 。 地黄提取物通过增加免疫细胞如嗜中性粒细胞或巨噬细胞的活性来增强动物的免疫力。 一种制备地黄提取物的方法，包括以下步骤：（a）用蒸馏水煮沸干燥的地黄，得到地黄提取物; （b）过滤提取物; 和（c）水解滤液。
-
公开(公告)号：KR1020080084384A
公开(公告)日：2008-09-19
申请号：KR1020070026062
申请日：2007-03-16
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K36/238 , A61P37/02
Abstract: An extract of Saposhnikovia root is provided to improve immune response by increasing activities of neutrophil, macrophage and lymphocyte, production of cytokines and non-specific protection against pathogenic bacteria infection in animals, so that it is useful as immunomodulator and immunoadjuvant. An extract of Saposhnikovia root for improving immune response in animals is prepared by heating Saposhnikovia root in water, and administered into an animal, especially domestic animals including cow, pig and chicken in the amount of 10-20 mg/kg per day through oral administration, intravenous injection, intramuscular injection or subcutaneous injection.
Abstract translation: 提供Saposhnikovia根的提取物，通过增加嗜中性粒细胞，巨噬细胞和淋巴细胞的活性，产生细胞因子和非特异性保护免受动物中的致病细菌感染来改善免疫应答，从而可用作免疫调节剂和免疫佐剂。 通过在水中加热山茱萸碱来制备Saposhnikovia根的提取物，并通过口服给药至每天10-20mg / kg的动物，特别是包括牛，猪和鸡的家畜，其量为10-20mg / kg ，静脉注射，肌内注射或皮下注射。
-
公开(公告)号：KR100850365B1
公开(公告)日：2008-08-05
申请号：KR1020070015656
申请日：2007-02-15
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
CPC classification number: A61K36/54 , A61K2236/331 , Y10S514/885
Abstract: A method for extracting Cinnamoni ramulus is provided to improve extraction yield of useful ingredients from Cinnamoni ramulus, so that the extract of Cinnamoni ramulus enhances immunity of animals, efficacy of vaccine and therapeutic effects of drugs. A method for extracting Cinnamoni ramulus comprises the steps of: mixing dried Cinnamoni ramulus with distilled water in a weight ratio of 1:4; heating the mixture to concentrate the solution; filtering the concentrated extract of Cinnamoni ramulus with filter paper; and filtering the firstly filtered solution with 0.45mum filter paper.
Abstract translation: 提供肉桂提取物提取方法，以提高肉桂樟脑中有用成分的提取率，从而提高肉桂的提取物，增强动物的免疫力，疫苗的疗效和药物的治疗效果。 一种提取肉桂樟脑的方法，包括以下步骤：将干果肉与蒸馏水混合，重量比为1：4; 加热混合物浓缩溶液; 用滤纸过滤浓缩的肉桂提取物; 并用0.45mum滤纸过滤第一次过滤的溶液。
-
69.发明授权
公开(公告)号：KR100270930B1
公开(公告)日：2000-11-01
申请号：KR1019980002745
申请日：1998-02-02
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: PURPOSE: A fusion cell line producing a monoclonal antibody specifically binding to E. coli O157 is provided to rapidly and exactly detect the infection of E. coli O157. CONSTITUTION: The microorganism NVRIO157(KCTC 0429BP) producing a monoclonal antibody specifically binding to E. coli O157 is produced by the steps of: immunizing a mouse with E. coli O157:H7 by injecting E. coli O157:H7 as an antigen into the mouse; separating immune cells that produce an antibody; and fusing the immune cells with myeloma cells to produce NVRIO157(KCTC 0429BP). The monoclonal antibody MNVRIO157 specifically binding to E. coli O157:H7 is produced from NVRIO157(KCTC 0429BP). The specificity of monoclonal antibody MNVRIO157 is analyzed by ELISA.
Abstract translation: 目的：提供产生与大肠杆菌O157特异性结合的单克隆抗体的融合细胞系，快速准确地检测大肠杆菌O157的感染。 构成：通过以下步骤产生产生与大肠杆菌O157特异性结合的单克隆抗体的微生物NVRIO157（KCTC 0429BP）：通过将大肠杆菌O157：H7作为抗原注射入到大肠杆菌O157：H7中免疫小鼠 老鼠; 分离产生抗体的免疫细胞; 并将免疫细胞与骨髓瘤细胞融合以产生NVRIO157（KCTC 0429BP）。 特异性结合大肠杆菌O157：H7的单克隆抗体MNVRIO157由NVRIO157（KCTC 0429BP）生产。 通过ELISA分析单克隆抗体MNVRIO157的特异性。
-
-
-
-
-
-
-
-
-
Search Results
92
records
(took 0.026 seconds)
